vs
AMERICAN SHARED HOSPITAL SERVICES（AMS）与Rocky Mountain Chocolate Factory, Inc.（RMCF）财务数据对比。点击上方公司名可切换其他公司
AMERICAN SHARED HOSPITAL SERVICES的季度营收约是Rocky Mountain Chocolate Factory, Inc.的1.0倍（$7.7M vs $7.5M），Rocky Mountain Chocolate Factory, Inc.净利率更高（-2.1% vs -8.2%，领先6.1%），Rocky Mountain Chocolate Factory, Inc.同比增速更快（-4.4% vs -14.8%），Rocky Mountain Chocolate Factory, Inc.自由现金流更多（$-1.3M vs $-2.7M），过去两年AMERICAN SHARED HOSPITAL SERVICES的营收复合增速更高（21.7% vs 1.9%）
美国共享医院服务公司为医疗机构提供放射治疗、立体定向放射外科及诊断成像设备的整体外包解决方案，免除医院高昂的前期资本投入，主要业务覆盖北美，同时服务拉美及部分亚太地区的公立、私立医院客户。
落基山巧克力厂是美国知名巧克力企业，同时开展国际特许经营业务，集糖果生产与零售运营于一体，总部位于美国科罗拉多州杜兰戈，除美国本土门店外，在巴拿马、菲律宾也设有经营网点。
AMS vs RMCF — 直观对比
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $7.7M | $7.5M |
| 净利润 | $-631.0K | $-155.0K |
| 毛利率 | 11.7% | 34.0% |
| 营业利润率 | -18.1% | 1.1% |
| 净利率 | -8.2% | -2.1% |
| 营收同比 | -14.8% | -4.4% |
| 净利润同比 | 52.5% | 81.7% |
| 每股收益（稀释后） | $-0.09 | $-0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $7.7M | $7.5M | ||
| Q3 25 | $7.2M | $6.8M | ||
| Q2 25 | $7.1M | $6.4M | ||
| Q1 25 | $6.1M | $8.9M | ||
| Q4 24 | $9.1M | $7.9M | ||
| Q3 24 | $7.0M | $6.4M | ||
| Q2 24 | $7.1M | $6.4M | ||
| Q1 24 | $5.2M | $7.3M |
| Q4 25 | $-631.0K | $-155.0K | ||
| Q3 25 | $-17.0K | $-662.0K | ||
| Q2 25 | $-280.0K | $-324.0K | ||
| Q1 25 | $-625.0K | $-2.9M | ||
| Q4 24 | $-1.3M | $-847.0K | ||
| Q3 24 | $-207.0K | $-722.0K | ||
| Q2 24 | $3.6M | $-1.7M | ||
| Q1 24 | $119.0K | $-1.6M |
| Q4 25 | 11.7% | 34.0% | ||
| Q3 25 | 22.1% | 23.6% | ||
| Q2 25 | 23.1% | 31.1% | ||
| Q1 25 | 15.4% | 10.8% | ||
| Q4 24 | 35.3% | 23.4% | ||
| Q3 24 | 19.6% | 31.8% | ||
| Q2 24 | 35.0% | 12.8% | ||
| Q1 24 | 41.1% | 24.3% |
| Q4 25 | -18.1% | 1.1% | ||
| Q3 25 | -4.8% | -7.0% | ||
| Q2 25 | -7.7% | -2.3% | ||
| Q1 25 | -21.3% | -30.3% | ||
| Q4 24 | -20.2% | -8.9% | ||
| Q3 24 | -12.7% | -14.3% | ||
| Q2 24 | -0.0% | -25.4% | ||
| Q1 24 | -1.6% | -21.7% |
| Q4 25 | -8.2% | -2.1% | ||
| Q3 25 | -0.2% | -9.7% | ||
| Q2 25 | -4.0% | -5.1% | ||
| Q1 25 | -10.2% | -32.5% | ||
| Q4 24 | -14.6% | -10.7% | ||
| Q3 24 | -3.0% | -11.3% | ||
| Q2 24 | 51.0% | -25.9% | ||
| Q1 24 | 2.3% | -21.9% |
| Q4 25 | $-0.09 | $-0.02 | ||
| Q3 25 | $0.00 | $-0.09 | ||
| Q2 25 | $-0.04 | $-0.04 | ||
| Q1 25 | $-0.10 | $-0.38 | ||
| Q4 24 | $-0.21 | $-0.11 | ||
| Q3 24 | $-0.03 | $-0.11 | ||
| Q2 24 | $0.55 | $-0.26 | ||
| Q1 24 | $0.02 | $-0.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.5M | $641.0K |
| 总债务越低越好 | $17.4M | — |
| 股东权益账面价值 | $24.0M | $6.0M |
| 总资产 | $55.5M | $20.7M |
| 负债/权益比越低杠杆越低 | 0.72× | — |
8季度趋势，按日历期对齐
| Q4 25 | $3.5M | $641.0K | ||
| Q3 25 | $5.1M | $2.0M | ||
| Q2 25 | $11.1M | $893.0K | ||
| Q1 25 | $11.2M | $720.0K | ||
| Q4 24 | $11.0M | $1.1M | ||
| Q3 24 | $13.8M | $973.0K | ||
| Q2 24 | $14.2M | $637.0K | ||
| Q1 24 | $12.8M | $2.1M |
| Q4 25 | $17.4M | — | ||
| Q3 25 | $18.2M | — | ||
| Q2 25 | $19.1M | — | ||
| Q1 25 | $19.9M | — | ||
| Q4 24 | $20.4M | — | ||
| Q3 24 | $14.4M | — | ||
| Q2 24 | $15.1M | — | ||
| Q1 24 | $15.6M | — |
| Q4 25 | $24.0M | $6.0M | ||
| Q3 25 | $24.6M | $6.1M | ||
| Q2 25 | $24.5M | $6.7M | ||
| Q1 25 | $24.6M | $7.0M | ||
| Q4 24 | $25.2M | $9.8M | ||
| Q3 24 | $26.4M | $10.5M | ||
| Q2 24 | $26.5M | $9.0M | ||
| Q1 24 | $22.8M | $10.6M |
| Q4 25 | $55.5M | $20.7M | ||
| Q3 25 | $59.6M | $22.3M | ||
| Q2 25 | $63.5M | $20.1M | ||
| Q1 25 | $63.3M | $21.2M | ||
| Q4 24 | $60.2M | $21.6M | ||
| Q3 24 | $63.3M | $21.1M | ||
| Q2 24 | $60.8M | $19.0M | ||
| Q1 24 | $50.1M | $20.6M |
| Q4 25 | 0.72× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.78× | — | ||
| Q1 25 | 0.81× | — | ||
| Q4 24 | 0.81× | — | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | 0.57× | — | ||
| Q1 24 | 0.68× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-704.0K | $-1.2M |
| 自由现金流经营现金流 - 资本支出 | $-2.7M | $-1.3M |
| 自由现金流率自由现金流/营收 | -34.8% | -16.9% |
| 资本支出强度资本支出/营收 | 25.7% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-8.5M | — |
8季度趋势，按日历期对齐
| Q4 25 | $-704.0K | $-1.2M | ||
| Q3 25 | $1.7M | $-488.0K | ||
| Q2 25 | $-372.0K | $350.0K | ||
| Q1 25 | $2.5M | $1.2M | ||
| Q4 24 | $274.0K | $-2.1M | ||
| Q3 24 | $472.0K | $-3.5M | ||
| Q2 24 | $1.3M | $-2.2M | ||
| Q1 24 | $-1.9M | $129.0K |
| Q4 25 | $-2.7M | $-1.3M | ||
| Q3 25 | $-2.0M | $-544.0K | ||
| Q2 25 | $-2.3M | $182.0K | ||
| Q1 25 | $-1.5M | — | ||
| Q4 24 | $-4.4M | — | ||
| Q3 24 | $-407.0K | $-4.6M | ||
| Q2 24 | $70.0K | $-2.6M | ||
| Q1 24 | $-3.0M | $-352.3K |
| Q4 25 | -34.8% | -16.9% | ||
| Q3 25 | -28.3% | -8.0% | ||
| Q2 25 | -32.1% | 2.9% | ||
| Q1 25 | -24.7% | — | ||
| Q4 24 | -48.4% | — | ||
| Q3 24 | -5.8% | -72.6% | ||
| Q2 24 | 1.0% | -40.2% | ||
| Q1 24 | -58.4% | -4.9% |
| Q4 25 | 25.7% | 0.5% | ||
| Q3 25 | 51.6% | 0.8% | ||
| Q2 25 | 26.9% | 2.6% | ||
| Q1 25 | 65.7% | — | ||
| Q4 24 | 51.4% | — | ||
| Q3 24 | 12.6% | 17.5% | ||
| Q2 24 | 17.2% | 6.5% | ||
| Q1 24 | 22.7% | 6.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.36× | — | ||
| Q1 24 | -15.67× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMS
| Direct Patient Services | $4.0M | 51% |
| Rental Income From Medical Services | $2.7M | 35% |
| Pbrt Services | $1.2M | 15% |
RMCF
| Manufacturing | $5.9M | 78% |
| Transferred At Point In Time | $1.2M | 16% |
| Other | $414.0K | 5% |
